The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies

Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia.

ESMO real world data and digital oncology·2026

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

Leukemia·2024

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Leukemia·2022

Evaluating ivosidenib for the treatment of acute myeloid leukemia.

Expert opinion on pharmacotherapy·2020

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Leukemia·2020

Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.

European journal of cancer (Oxford, England : 1990)·2026

First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort.

European journal of cancer (Oxford, England : 1990)·2026

Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcinoma: A propensity score matched analysis of patients from a Dutch National and US institutional cohort.

European journal of cancer (Oxford, England : 1990)·2026

Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study.

European journal of cancer (Oxford, England : 1990)·2026

Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E).

European journal of cancer (Oxford, England : 1990)·2026

Frozen section analysis assisted MRI targeted prostate biopsy - results of the randomized clinical FAST trial.

European journal of cancer (Oxford, England : 1990)·2026

Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease.

Liver international : official journal of the International Association for the Study of the Liver·2026

Acute colonic variceal bleeding treated with coil-assisted retrograde transvenous obliteration following atezolizumab-bevacizumab therapy for advanced hepatocellular carcinoma: A case report.

Medicine·2026

FXI and FXII in experimental stroke and FXI in clinical stroke trials.

Neurological research and practice·2026

Persistent CAR-T donor cells contribute to mixed chimerism with cytopenia after CAR-T-bridged allo-HSCT: rescue by CAR-target-knockout DLI in three cases.

Biomarker research·2026

Uterine leiomyomas in HLRCC: a scoping review of presentation, histopathology, treatment patterns, and reproductive implications.

European journal of human genetics : EJHG·2026

A non-enzymatic C-type lectin from bullhead shark Heterodontus japonicus skin amplifies coagulation via common-pathway downstream of factor Xa.

Biochimie·2026

Related Experiment Videos

The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies

Related Concept Videos

Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia.

Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial.

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Evaluating ivosidenib for the treatment of acute myeloid leukemia.

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS.

Lazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.

First-line fluoropyrimidine- versus gemcitabine-based chemotherapy for metastatic recurrence after resection of ampullary adenocarcinoma: A real-world analysis of the FFCD-AC cohort.

Survival benefit of recurrence-focused treatment after surgery for pancreatic ductal adenocarcinoma: A propensity score matched analysis of patients from a Dutch National and US institutional cohort.

Perioperative chemotherapy and long-term cure in resected grade 3 gastroenteropancreatic neuroendocrine carcinomas: The GETNE SOUTH-NEC Study.

Pain in epithelioid hemangioendothelioma: Development of disease-specific pain assessment criteria (PAC-E).

Frozen section analysis assisted MRI targeted prostate biopsy - results of the randomized clinical FAST trial.

Hepatic Progenitor Cells and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease.

Acute colonic variceal bleeding treated with coil-assisted retrograde transvenous obliteration following atezolizumab-bevacizumab therapy for advanced hepatocellular carcinoma: A case report.

FXI and FXII in experimental stroke and FXI in clinical stroke trials.

Persistent CAR-T donor cells contribute to mixed chimerism with cytopenia after CAR-T-bridged allo-HSCT: rescue by CAR-target-knockout DLI in three cases.

Uterine leiomyomas in HLRCC: a scoping review of presentation, histopathology, treatment patterns, and reproductive implications.

A non-enzymatic C-type lectin from bullhead shark Heterodontus japonicus skin amplifies coagulation via common-pathway downstream of factor Xa.

Related Experiment Videos

The prophylactic use of fluconazole 50 vs. 100 mg daily in haematological malignancies

Related Concept Videos

Related Articles